Company: BLTE
Filing Date: 2025-10-22
Form Type: F-3ASR
Source: 0001104659-25-101403
Chunk: 2

Company: BELITE BIO, INC
Filing Date: 2025-10-22
Form: F-3ASR
Chunk 2
---
, we refer to warrants issued to the Selling Shareholder as “Warrants.”

We will not receive any proceeds from the offer and sale of the ADSs by the Selling Shareholder under this prospectus, but will incur expenses in connection with the registration of these offered securities. However, we could receive up to approximately US$150 million in gross proceeds if the Warrants are exercised in full for cash. We are filing this prospectus primarily pursuant to contractual obligations that exist with the Selling Shareholders.

Information regarding the Selling Shareholders, the number of ADSs that may be sold by them, and the times and manner in which they may offer and sell the ADSs under this prospectus is provided under the sections titled “Selling Shareholders” and “Plan of Distribution.” The registration of the offer and resale of the offered securities does not necessarily mean that the Selling Shareholders will offer or sell such securities. We cannot predict when or in what amounts the Selling Shareholders may sell any of such securities offered by this prospectus. The Selling Shareholders may sell any, all, or none of the securities offered by this prospectus. The Selling Shareholders and intermediaries through whom such securities are sold may be deemed “underwriters” within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), with respect to the securities offered hereby, and any profits realized or commissions received may be deemed underwriting compensation.

The Warrants are exercisable immediately upon issuance and will expire two years from the date of issuance. See “Description of the Warrants” in this prospectus for more information.

We are a “foreign private issuer” under applicable U.S. federal securities laws and are eligible for reduced public company reporting requirements. See “Our Company — Implications of Being a Foreign Private Issuer” for additional information.

Our ADSs are quoted on the Nasdaq Capital Market under the symbol “BLTE.” On October 21, 2025, the last reported sale price of our ADSs on Nasdaq was $92.00 per ADS. There is no established public trading market for the Warrants, and we do not expect one to develop. We do not intend to apply to list the Warrants on any securities exchange.

Investing in our securities involves risks. We are a holding company incorporated in the Cayman Islands. As a holding company with no material operations of our own, we conduct operations primarily through our direct and indirect wholly owned subsidiaries in the US, Australia, Hong Kong and the People’s